Cic edizioni internazionali
Clinical Cases in mineral and bone metabolism

The role of drugs in bone pain

Mini-review, 93 - 96
doi: 10.11138/ccmbm/2016.13.2.093
Tag this article
Abstract
Full text PDF
Painful symptomatology in the skeletal system can be found in various pathological conditions and can be either localised or diffused. Bone tenderness is common in those who are of an elderly age.
Treatment strategy. Patients should be informed of the possible causes of their pain and the different therapies that could alleviate it; furthermore they should be encouraged to have an active role in their therapy. It is necessary to prevent the onset of the pain (by the clock) by considering the biological half-life, the bioavailability and the duration of action of the therapy.
According to the World Health Organization (WHO), pain treatment is based on a three-step ladder.
Adjuvant therapies. Adjuvant therapies are often associated with the drugs in the WHO three step ladder. This heterogeneous group of non-analgesic drugs is used in the treatment of bone pain by bettering the analgesia or reducing the side effects brought on by analgesics.
Conclusion. In the daily struggle that doctors face to treat their patients, pain management should not be disregarded.
Among the various types of pain, bone pain, must not be underestimated but be fought against by using all means available. Patients need to be treated depending on the severity of their pain, NSAIDs should be the preferred choice of treatment for acute pain but not for that of chronic pain. In the case of chronic pain opioids should be used in their most recent fomulations as they can guarantee fewer side effects. Patients should also be prescribed adjuvant drugs as well as being given psychological support in order to ensure successful treatment.

Vol. XIII (No. 2) 2016 May-August

  1. From the Editor-in-Chief
    Brandi M.L.
  2. Calcio, vitamina D e fratture: domande e risposte
    Brandi M.L.
    doi: 10.11138/ccmbm/2016.13.2.081
  3. Implications of analgesics use in osteoporotic-related pain treatment: focus on opioids
    Vellucci R., Mattia C., Celidonio L., Mediati R.D.
    doi: 10.11138/ccmbm/2016.13.2.089
  4. The role of drugs in bone pain
    Marras F., Tranquilli Leali P.
    doi: 10.11138/ccmbm/2016.13.2.093
  5. Bone pain mechanism in osteoporosis: a narrative review
    Mattia C., Coluzzi F., Celidonio L., Vellucci R.
    doi: 10.11138/ccmbm/2016.13.2.097
  6. Bone healing in 2016
    Buza III J.A., Einhorn T.
    doi: 10.11138/ccmbm/2016.13.2.101
  7. Abaloparatide
    Gonnelli S., Caffarelli C.
    doi: 10.11138/ccmbm/2016.13.2.106
  8. Hereditary Multiple Exostoses: a review of clinical appearance and metabolic pattern
    Beltrami G., Ristori G., Scoccianti G., Tamburini A., Capanna R.
    doi: 10.11138/ccmbm/2016.13.2.110
  9. Underdiagnosis of osteoporotic vertebral fractures in patients with fragility fractures: retrospective analysis of over 300 patients
    Bottai V., Giannotti S., Raffaetà G., Mazzantini M., Casella F., De Paola G., Menconi A., Falossi F., Guido G.
    doi: 10.11138/ccmbm/2016.13.2.119
  10. Risk factors of mortality during the first year after low energy osteoporosis fracture: a retrospective case-control study
    Lloret A., Coiffier G., Couchouron T., Perdriger A., Guggenbuhl P.
    doi: 10.11138/ccmbm/2016.13.2.123
  11. Rates and reasons for lack of persistence with anti-osteoporotic drugs: analysis of the Campania region database
    Iolascon G., Gimigliano F., Moretti A., Riccio I., Di Gennaro M., Illario M., Monetti V.M., Orlando V., Menditto E.
    doi: 10.11138/ccmbm/2016.13.2.127
  12. Hyaluronic acid in the management of osteoarthritis: injection therapies innovations
    Santilli V., Paoloni M., Mangone M., Alviti F., Bernetti A.
    doi: 10.11138/ccmbm/2016.13.2.131
  13. The use of routine non density calibrated clinical computed tomography data as a potentially useful screening tool for identifying patients with osteoporosis
    Burke C.J., Didolkar M.M., Barnhart H.X., Vinson E.N.
    doi: 10.11138/ccmbm/2016.13.2.135
  14. Evaluation of the bone mineral density of the subjects with avascular necrosis of hip joint
    Taghi Karimi M., Mousavi Nodoshan S.M.
    doi: 10.11138/ccmbm/2016.13.2.141
  15. Densitometric evaluation of bone-prosthetic counterface in hip and knee arthroplasty with modern implants
    Cozzi Lepri A., Giorgini M., Signorini C., Carulli C., Civinini R., Brandi M.L., Innocenti M.
    doi: 10.11138/ccmbm/2016.13.2.144
  16. Low-energy trauma-induced intercondylar femoral fracture
    Aeby M., Wyss T., Mentrup B., Kunstmann E., Jakob F., Aeberli D.
    doi: 10.11138/ccmbm/2016.13.2.151
  17. Early onset acute tubular necrosis following single infusion of zoledronate
    Yachoui R.
    doi: 10.11138/ccmbm/2016.13.2.154
  18. Concomitant extraspinal hyperostosis and osteoporosis in a patient with congenital ichthyosis
    Torkamani N., Phal P., Savarirayan R., Simm P., Varigos G., Wark J.
    doi: 10.11138/ccmbm/2016.13.2.157
Last Viewed articles: la lista degli ultimi x visitati.
  1. The role of drugs in bone pain
    Marras F., Tranquilli Leali P.
    doi: 10.11138/ccmbm/2016.13.2.093
credits